News 28

Biogen and Eisai report successful test on Alzheimer’s treatment

SKIP AD >
CNBC's Shep Smith reports on positive news regarding a drug trial from Biogen and Japan's Eisai, which showed a 27% decrease in cognitive decline among early stage Alzheimer's patients.

FOLLOW US!

See more +